Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2026-01-07 @ 8:05 AM
Study NCT ID:
NCT03394027
Status:
COMPLETED
Last Update Posted:
2022-08-23
First Post:
2018-01-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-07
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-05
First Submit QC Date:
None
Study First Post Date:
2018-01-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-12-17
Results First Submit QC Date:
None
Results First Post Date:
2022-01-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-28
Last Update Post Date:
2022-08-23
Last Update Post Date Type:
ACTUAL